Dr. Schwegman is the founder and CEO of AB BioTechnologies, Inc. (AB), a contract development and manufacturing organization (CDMO) located in Bloomington, Indiana. AB is an internationally renowned leader in lyophilization and formulation development for small and large molecules, suspension, emulsions, tissues, and diagnostic products. The company offers corresponding process development and analytical services as supplements and standalone projects. Dr. Schwegman received his BS in Biochemistry from Indiana University, and completed his Ph.D. from Purdue University in Industrial and Physical Pharmacy.